NYSTATIN FORMULATION HAVING REDUCED TOXICITY

摘要

The present invention provides a novel formulation of nystatin for parenteral administration to treat systemic fungal infections. The formulation avoids the toxicity and solubility problems of prior art nystatin formulations.